In human cancer, the CXCR2 ligand CXCL8 (IL-8) is abundantly secreted by various tumor types (Sanmamed et al., 2014) and is sufficient to regulate neutrophil recruitment and NETosis (Alfaro et al., 2016; Nie et al., 2019). This evidence concerns the gene CXCR2 and neoplasm.